Related references
Note: Only part of the references are listed.Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials
Julia Bohlius et al.
LANCET (2009)
Retrospective review of hemoglobin and/or hematocrit levels with occurrence of thrombosis in cancer patients treated with erythropoiesis stimulating agents
Amber C Fullmer et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE (2009)
Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia
Charles L. Bennett et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Cerebrovascular Disease Risk in Older Head and Neck Cancer Patients After Radiotherapy
Grace L. Smith et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Evaluation of trends in the cost of initial cancer treatment
Joan L. Warren et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Efficacy and safety of epoetin alfa in critically ill patients
Howard L. Corwin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Racial disparities and socioeconomic status in association with survival in a large population-based cohort of elderly patients with colon cancer
Xianglin L. Du et al.
CANCER (2007)
Radiation therapy, cardiac risk factors, and cardiac toxicity in early-stage breast cancer patients
John J. Doyle et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
Randomized, double-blind, placebo-controlled trial of erythropoietin in non-small-cell lung cancer with disease-related anemia
James R. Wright et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Late gastrointestinal toxicity after radiation for prostate cancer
Sharon H. Giordano et al.
CANCER (2006)
Supraclavicular radiation for breast cancer does not increase the 10-year risk of stroke
Wendy A. Woodward et al.
CANCER (2006)
Recombinant human erythropoietins and cancer patients: Updated meta-analysis of 57 studies including 9353 patients
Julia Bohlius et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Outpatient gatifloxacin therapy and dysglycemia in older adults
LY Park-Wyllie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Erythropoietin or Darbepoetin for patients with cancer
J. Bohlius et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2006)
Oral erythromycin and the risk of sudden death from cardiac causes
WA Ray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Postmarketing surveillance for drug safety: Surely we can do better
MR Griffin et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy:: randomised, double-blind, placebo-controlled trial
M Henke et al.
LANCET (2003)
Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: Results of a randomized, double-blind, placebo-controlled trial
TJ Littlewood et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Development of a comorbidity index using physician claims data
CN Klabunde et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2000)
Share Paper
